Adia Nutrition Unveils Exclusive Artwork by Renowned Performance Artist Rock Demarco at First Clinic
17 déc. 2024 09h00 HE
|
ADIA Nutrition
WINTER PARK, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is excited to announce the installation of an exclusive artwork by the renowned performance artist and speed painter, Rock...
Adia Nutrition Opens Doors in Winter Park, FL, Now Accepting Patients for AHSCT and Regenerative Therapies
10 déc. 2024 09h00 HE
|
ADIA Nutrition
WINTER PARK, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition is thrilled to announce the opening of its inaugural clinic in Winter Park, Florida. The state-of-the-art facility is now...
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
06 déc. 2024 07h30 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
04 déc. 2024 08h00 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division
CORRECTION - Elevai Labs Inc.
14 nov. 2024 14h35 HE
|
Elevai Labs Inc.
/CORRECTION/ Elevai Labs Inc. Reports Financial Results for the Third Fiscal Quarter of 2024 and Provides Business Update
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
14 nov. 2024 09h08 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
13 nov. 2024 16h14 HE
|
NurExone Biologic Inc
European Medicines Agency Awards Orphan Status to NurExone's ExoPTEN for Spinal Cord Injury, Paving the Way to European Market Entry
NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA
23 oct. 2024 02h56 HE
|
NurExone Biologic Inc
NurExone’s Groundbreaking Exosome Therapies to be Showcased at Fall U.S. Conferences
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device
02 oct. 2024 08h30 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medic
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
26 sept. 2024 16h03 HE
|
NurExone Biologic Inc
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M